laquinimod

Indications

• relapsing-remitting multiple sclerosis (investigational)

Dosage

• 0.6 mg PO QD

Adverse effects

• slightly more common than placebo
  • back pain
  • GI symptoms
  • cough
  • minor infections
    • urinary tract infection
    • sinusitis
• elevated serum AST, serum ALT (1%)

Mechanism of action

• anti-inflammatory properties

More general terms

• quinolone
• neurologic agent

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=54677946
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=23697158